Literature DB >> 26739872

Augmented circadian rhythm of the intrarenal renin-angiotensin systems in anti-thymocyte serum nephritis rats.

Shinsuke Isobe1, Naro Ohashi1, Sayaka Ishigaki1, Takayuki Tsuji1, Yukitoshi Sakao2, Akihiko Kato2, Hiroaki Miyajima1, Yoshihide Fujigaki1,3, Akira Nishiyama4, Hideo Yasuda1.   

Abstract

We report that disturbance to the circadian rhythm of urinary angiotensinogen (AGT) excretion may lead to renal damage, hypertension and diurnal blood pressure (BP) variations. We aim to clarify the circadian rhythm of the intrarenal renin-angiotensin system (RAS) and its contribution to renal damage, hypertension and BP variations, and to evaluate whether the administration of RAS blockers influences the circadian rhythms of intrarenal RAS components. Anti-thymocyte serum (ATS) nephritis rats were used as a chronic progressive glomerulonephritis model (group A) and compared with control rats (group C). Other rats with ATS nephritis received olmesartan medoxomil (an angiotensin II (AngII) type 1 receptor (AT1R) blocker; group AO) or hydralazine (a vasodilator; group AH). The levels of intrarenal RAS components were evaluated every 6 h. The expression levels of intrarenal AGT, AngII and AT1R were increased in group A and peaked at the same time as BP and urinary protein excretion during the rest phase. The amplitude of the circadian fluctuation of these proteins was more increased in group A than in group C. The circadian fluctuation of these proteins was reduced in groups AO and AH. However, renal function, proteinuria and augmentation of intrarenal RAS components were reduced only in group AO. Intrarenal RAS components, such as AGT, AngII and AT1R proteins, were increased and the amplitude of the oscillations of these proteins was augmented in ATS nephritis rats. Interestingly, renal damage may be linked to the activation of the intrarenal RAS independent of the amplitude of its oscillations and BP.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26739872     DOI: 10.1038/hr.2015.151

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  37 in total

Review 1.  Kidney in hypertension: guyton redux.

Authors:  Thomas M Coffman; Steven D Crowley
Journal:  Hypertension       Date:  2008-03-10       Impact factor: 10.190

2.  Angiotensin receptor blockers shift the circadian rhythm of blood pressure by suppressing tubular sodium reabsorption.

Authors:  Michio Fukuda; Tamaki Wakamatsu-Yamanaka; Masashi Mizuno; Toshiyuki Miura; Tatsuya Tomonari; Yoko Kato; Tadashi Ichikawa; Sota Miyagi; Yuichi Shirasawa; Akinori Ito; Atsuhiro Yoshida; Genjiro Kimura
Journal:  Am J Physiol Renal Physiol       Date:  2011-08-24

3.  [Diurnal profiles of plasma aldosterone, cortisol, renin, angiotensinogen and angiotensinases in normal subjects (author's transl)].

Authors:  D Lommer; A Distler; H P Nast; K Sinterhauf; U Walter; H P Wolff; K Sieler
Journal:  Klin Wochenschr       Date:  1976-02-01

4.  Enhanced intrarenal receptor-mediated prorenin activation in chronic progressive anti-thymocyte serum nephritis rats on high salt intake.

Authors:  Yanjie Huang; Tatsuo Yamamoto; Taro Misaki; Hiroyuki Suzuki; Akashi Togawa; Naro Ohashi; Hirotaka Fukasawa; Yoshihide Fujigaki; Atsuhiro Ichihara; Akira Nishiyama; Takaaki Senbonmatsu; Naoki Ikegaya; Akira Hishida
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-11

5.  Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation.

Authors:  Taiji Matsusaka; Fumio Niimura; Ira Pastan; Ayumi Shintani; Akira Nishiyama; Iekuni Ichikawa
Journal:  Kidney Int       Date:  2013-11-27       Impact factor: 10.612

6.  Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man.

Authors:  A M Richards; M G Nicholls; E A Espiner; H Ikram; M Cullens; D Hinton
Journal:  Clin Exp Hypertens A       Date:  1986

7.  Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats.

Authors:  Naro Ohashi; Tatsuo Yamamoto; Yanjie Huang; Taro Misaki; Hirotaka Fukasawa; Hiroyuki Suzuki; Akashi Togawa; Sayuri Suzuki; Yoshihide Fujigaki; Tsutomu Nakagawa; Yukio Nakamura; Fumiaki Suzuki; Masatoshi Kitagawa; Akira Hishida
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-10

8.  Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling.

Authors:  Hirotaka Fukasawa; Tatsuo Yamamoto; Hiroyuki Suzuki; Akashi Togawa; Naro Ohashi; Yoshihide Fujigaki; Chiharu Uchida; Michiko Aoki; Mareto Hosono; Masatoshi Kitagawa; Akira Hishida
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

9.  Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy.

Authors:  Michio Fukuda; Miwa Munemura; Takeshi Usami; Naoyuki Nakao; Oki Takeuchi; Yoshinobu Kamiya; Atsuhiro Yoshida; Genjiro Kimura
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

10.  Circadian rhythm of plasma and urinary angiotensinogen in healthy volunteers and in patients with chronic kidney disease.

Authors:  Yoko Nishijima; Hiroyuki Kobori; Kumiko Kaifu; Tomoko Mizushige; Taiga Hara; Akira Nishiyama; Masakazu Kohno
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-11-07       Impact factor: 1.636

View more
  16 in total

Review 1.  Circadian rhythm of blood pressure and the renin-angiotensin system in the kidney.

Authors:  Naro Ohashi; Shinsuke Isobe; Sayaka Ishigaki; Hideo Yasuda
Journal:  Hypertens Res       Date:  2016-12-01       Impact factor: 3.872

2.  Intrarenal renin-angiotensin system activity is augmented after initiation of dialysis.

Authors:  Naro Ohashi; Shinsuke Isobe; Sayaka Ishigaki; Takahisa Suzuki; Masafumi Ono; Tomoyuki Fujikura; Takayuki Tsuji; Akihiko Kato; Seiichiro Ozono; Hideo Yasuda
Journal:  Hypertens Res       Date:  2016-10-20       Impact factor: 3.872

Review 3.  Diurnal Regulation of Renal Electrolyte Excretion: The Role of Paracrine Factors.

Authors:  Dingguo Zhang; David M Pollock
Journal:  Annu Rev Physiol       Date:  2019-10-21       Impact factor: 19.318

4.  Intrarenal renin-angiotensin system activation in end-stage renal disease.

Authors:  Maki Urushihara; Hiroyuki Kobori
Journal:  Hypertens Res       Date:  2017-02-09       Impact factor: 3.872

5.  Melatonin ameliorates intrarenal renin-angiotensin system in a 5/6 nephrectomy rat model.

Authors:  Sayaka Ishigaki; Naro Ohashi; Takashi Matsuyama; Shinsuke Isobe; Naoko Tsuji; Takamasa Iwakura; Tomoyuki Fujikura; Takayuki Tsuji; Akihiko Kato; Hiroaki Miyajima; Hideo Yasuda
Journal:  Clin Exp Nephrol       Date:  2017-11-20       Impact factor: 2.801

Review 6.  Role of the intrarenal renin-angiotensin system in the progression of renal disease.

Authors:  Maki Urushihara; Shoji Kagami
Journal:  Pediatr Nephrol       Date:  2016-07-05       Impact factor: 3.714

7.  Circadian rhythm of the intrarenal renin-angiotensin system is caused by glomerular filtration of liver-derived angiotensinogen depending on glomerular capillary pressure in adriamycin nephropathy rats.

Authors:  Takashi Matsuyama; Naro Ohashi; Taro Aoki; Sayaka Ishigaki; Shinsuke Isobe; Taichi Sato; Tomoyuki Fujikura; Akihiko Kato; Hiroaki Miyajima; Hideo Yasuda
Journal:  Hypertens Res       Date:  2021-02-08       Impact factor: 3.872

8.  Cytoresistance after acute kidney injury is limited to the recovery period of proximal tubule integrity and possibly involves Hippo-YAP signaling.

Authors:  Takamasa Iwakura; Yoshihide Fujigaki; Tomoyuki Fujikura; Takayuki Tsuji; Naro Ohashi; Akihiko Kato; Hideo Yasuda
Journal:  Physiol Rep       Date:  2017-06

Review 9.  Circadian Control of Sodium and Blood Pressure Regulation.

Authors:  Reham H Soliman; David M Pollock
Journal:  Am J Hypertens       Date:  2021-11-20       Impact factor: 3.080

10.  [Size exclusion-reverse liquid column chromatography-mass spectrometry and its application in the identification of post-translationally modified proteins in rat kidney].

Authors:  Jianmin Li; Yue Zhuo; Yida Zhang; Na Li; Jianlin Wu
Journal:  Se Pu       Date:  2021-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.